Breast Cancer Survival
Age adjustment should be made for long-term survivors treated with breast conserving therapy
Published in Cancer Weekly, November 1st, 2005
The aim of a study by investigators in Germany was "to compare the functional status in long-term breast cancer survivors related to age at diagnosis and to asses the effects of adjuvant therapy on health-related quality of life (HRQoL)."
F. Fehlauer and colleagues obtained "Data from 370 patients after breast conserving therapy (BCT) at follow-up (F/U) visit. The self-administered EORTC QoL questionnaire (C30) and the breast module (QLQ-BR23) measuring global health, global QoL, physical, role, emotional, cognitive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-11-01)
More Articles from Cancer Weekly
- Anticancer Drugs
TrxR inhibition contributes to cytotoxicity of anticancer compounds - Cancer Risk Factors
Susceptibility to carcinogens increased with early-life exposure - Cancer Therapy
Adjuvant chemotherapy proposed for stage II colorectal cancer - Leukemia
AMN107 performed better as inhibitor of Ph-positive leukemia than imatinib - Paclitaxel
Combination therapy had significant effect on reduction of prostate tumor volume - Alternative Surgery
Median sternotomy proposed as alternate approach to extrapleural pneumonectomy - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
